Skip to main navigation Skip to search Skip to main content

Ropinirole in Bipolar Disorder: Rate of Manic Switching and Change in Disease Severity

  • Horacio A. Capote
  • , Michelle Rainka
  • , Erica S. Westphal
  • , Jonathan Beecher
  • , Francis M. Gengo
  • Dent. Neurologic Institute

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

PURPOSE: To determine the effects of ropinirole on manic switching and disease severity in bipolar disorder. DESIGN AND METHODS: A cross-sectional survey was conducted in 23 bipolar depressed patients using ropinirole combination therapy (Young Mania Rating Scale [YMRS], Bipolar Inventory of Symptoms Scale [BISS]). Retrospective Clinical Global Impression of Change (CGI-C) and CGI-S (Severity) were captured via chart review. FINDINGS: One patient (4.3%) experienced induction of mania (YMRS). All patients responded or partially responded to ropinirole (CGIs). YMRS and BISS mania scores were correlated. PRACTICE IMPLICATIONS: Ropinirole has a low rate of manic switching and significantly reduces bipolar depression severity.

Original languageEnglish
Pages (from-to)100-106
Number of pages7
JournalPerspectives in Psychiatric Care
Volume54
Issue number2
DOIs
StatePublished - Apr 2018

Keywords

  • bipolar
  • BISS
  • dopamine agonists
  • mania
  • ropinirole
  • YMRS

Fingerprint

Dive into the research topics of 'Ropinirole in Bipolar Disorder: Rate of Manic Switching and Change in Disease Severity'. Together they form a unique fingerprint.

Cite this